头孢孟多酯钠结构式
|
常用名 | 头孢孟多酯钠 | 英文名 | Cefamandole nafate |
---|---|---|---|---|
CAS号 | 42540-40-9 | 分子量 | 512.495 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C19H17N6NaO6S2 | 熔点 | 190-193ºC | |
MSDS | N/A | 闪点 | N/A | |
符号 |
GHS07, GHS08 |
信号词 | Danger |
头孢孟多酯钠用途Cefamandole钠盐是第二代广谱头孢菌素抗生素。 |
中文名 | 头孢孟多酯钠 |
---|---|
英文名 | cefamandole nafate |
中文别名 | 7-D-(2-甲酰氧苯乙酰胺)-3-[(1-甲基-1H-四唑-5-基)硫甲基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-甲酸钠盐 | 头孢羟唑 |
英文别名 | 更多 |
熔点 | 190-193ºC |
---|---|
分子式 | C19H17N6NaO6S2 |
分子量 | 512.495 |
精确质量 | 512.054871 |
PSA | 210.04000 |
外观性状 | 白色固体 |
储存条件 | -20?C Freezer, Under Inert Atmosphere |
符号 |
GHS07, GHS08 |
---|---|
信号词 | Danger |
危害声明 | H315-H317-H319-H334-H335 |
警示性声明 | P261-P280-P284-P304 + P340-P305 + P351 + P338-P342 + P311 |
危害码 (欧洲) | Xn |
风险声明 (欧洲) | 36/37/38-42/43 |
安全声明 (欧洲) | 26-36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | XI0380000 |
海关编码 | 3003201900 |
~% 头孢孟多酯钠 42540-40-9 |
文献:DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; Location in patent: Page/Page column 11 ; |
~% 头孢孟多酯钠 42540-40-9 |
文献:DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; |
~% 头孢孟多酯钠 42540-40-9 |
文献:DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; |
~% 头孢孟多酯钠 42540-40-9 |
文献:DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; |
头孢孟多酯钠上游产品 4 | |
---|---|
头孢孟多酯钠下游产品 0 |
海关编码 | 3003201900 |
---|
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, (6R,7R)- |
Mandokef |
Cefam |
cephamandole nafate |
EINECS 255-877-4 |
Cefamandole nafate |
O-Formylcefamandole sodium |
Bergacef |
Cedol |
Cemandil |
(6R-(6a,7b(R*)))-7-(((Formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Monosodium Sal |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt, (6R,7R)- (1:1) |
CefamandoleNafate |
Cefamandole formate sodium |
Mandol |
Cemandil sodium salt |
Cefaseptolo |
Sodium O-formylcefamandole |
Mandolsan |
UNII-8HDO7941DO |
Cefamandole formate sodium salt |
Sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
Kefadol |
MFCD00864877 |
Cefamandole (nafate) |